Tapewire

Nasdaq · USD

RGNX

REGENXBIO Inc.

Export transactions ↓
Tapewire entity
2211
SEC CIK
0001590877
Parsed reports
367

Last 12 months

Inside the activity.

2 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202601
Jun 202601
Jul 202602
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 18, 2019 Filed Apr 22, 2019 20:17 UTC
Christmas Patrick J.SVP, General Counsel
Exercise / conversionStock Option (Right to Buy) · Derivative 1,459 $0.00 Strike: $19.50 $0.00
Disclosure

SEC source: 0001562180-19-002324 · primarydocument.xml · derivative · entry 8

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,641

Underlying: Common Stock · 1,459 shares

Expires 2027-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 11,100 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
April 18, 2019 Filed Apr 22, 2019 20:17 UTC
Christmas Patrick J.SVP, General Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 3,541 $0.00 Strike: $12.10 $0.00
Disclosure

SEC source: 0001562180-19-002324 · primarydocument.xml · derivative · entry 7

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,931

Underlying: Common Stock · 3,541 shares

Expires 2026-08-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
April 18, 2019 Filed Apr 22, 2019 20:17 UTC
Christmas Patrick J.SVP, General Counsel
SaleCommon Stock 100 $55.50 $5,550.00
Disclosure

SEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 6

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,006

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 18, 2019 Filed Apr 22, 2019 20:17 UTC
Christmas Patrick J.SVP, General Counsel
SaleCommon Stock 885 $54.66 $48,374.10
Disclosure

SEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 5

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,106

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $54.32 to $55.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 18, 2019 Filed Apr 22, 2019 20:17 UTC
Christmas Patrick J.SVP, General Counsel
SaleCommon Stock 1,115 $53.67 $59,842.05
Disclosure

SEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 4

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,991

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $53.20 to $54.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 18, 2019 Filed Apr 22, 2019 20:17 UTC
Christmas Patrick J.SVP, General Counsel
SaleCommon Stock 2,900 $52.55 $152,395.00
Disclosure

SEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 3

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,106

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $52.12 to $53.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 18, 2019 Filed Apr 22, 2019 20:17 UTC
Christmas Patrick J.SVP, General Counsel
Exercise / conversionCommon Stock 1,459 $19.50 $28,450.50
Disclosure

SEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 2

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,006

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 18, 2019 Filed Apr 22, 2019 20:17 UTC
Christmas Patrick J.SVP, General Counsel
Exercise / conversionCommon Stock 3,541 $12.10 $42,846.10
Disclosure

SEC source: 0001562180-19-002324 · primarydocument.xml · nonDerivative · entry 1

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,547

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 17, 2019 Filed Apr 19, 2019 20:14 UTC
PAKOLA STEVEChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 95,000 $0.00 Strike: $54.72 $0.00
Disclosure

SEC source: 0001562180-19-002311 · primarydocument.xml · derivative · entry 1

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Common Stock · 95,000 shares

Expires 2029-04-17

F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following April 17, 2020 while the optionee provides continuous service to the Issuer.

Read SEC document
April 15, 2019 Filed Apr 17, 2019 16:19 UTC
Danos OlivierChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $20.35 $0.00
Disclosure

SEC source: 0001562180-19-002295 · primarydocument.xml · derivative · entry 4

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,500

Underlying: Common Stock · 2,000 shares

Expires 2027-03-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 100,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on March 27, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
April 15, 2019 Filed Apr 17, 2019 16:19 UTC
Danos OlivierChief Scientific Officer
SaleCommon Stock 1,000 $53.09 $53,090.00
Disclosure

SEC source: 0001562180-19-002295 · primarydocument.xml · nonDerivative · entry 3

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,500

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $52.94 to $53.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 15, 2019 Filed Apr 17, 2019 16:19 UTC
Danos OlivierChief Scientific Officer
SaleCommon Stock 1,000 $52.23 $52,230.00
Disclosure

SEC source: 0001562180-19-002295 · primarydocument.xml · nonDerivative · entry 2

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $51.88 to $52.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 15, 2019 Filed Apr 17, 2019 16:19 UTC
Danos OlivierChief Scientific Officer
Exercise / conversionCommon Stock 2,000 $20.35 $40,700.00
Disclosure

SEC source: 0001562180-19-002295 · primarydocument.xml · nonDerivative · entry 1

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 21, 2019 Filed Mar 25, 2019 12:32 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 1,700 $61.31 $104,227.00
Disclosure

SEC source: 0001562180-19-002018 · primarydocument.xml · nonDerivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,215

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $61.12 to $61.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 21, 2019 Filed Mar 25, 2019 12:32 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 8,300 $60.64 $503,312.00
Disclosure

SEC source: 0001562180-19-002018 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,915

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $60.12 to $61.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 19, 2019 Filed Mar 21, 2019 20:17 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-19-002005 · primarydocument.xml · derivative · entry 4

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,670

Underlying: Common Stock · 15,000 shares

Expires 2024-09-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.

Read SEC document
March 19, 2019 Filed Mar 21, 2019 20:17 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 9,130 $58.74 $536,296.20
Disclosure

SEC source: 0001562180-19-002005 · primarydocument.xml · nonDerivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $58.51 to $59.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 19, 2019 Filed Mar 21, 2019 20:17 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 5,870 $58.21 $341,692.70
Disclosure

SEC source: 0001562180-19-002005 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,130

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $57.51 to $58.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 19, 2019 Filed Mar 21, 2019 20:17 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 15,000 $0.85 $12,750.00
Disclosure

SEC source: 0001562180-19-002005 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 12, 2019 Filed Mar 14, 2019 16:17 UTC
Danos OlivierChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $20.35 $0.00
Disclosure

SEC source: 0001562180-19-001906 · primarydocument.xml · derivative · entry 2

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,500

Underlying: Common Stock · 5,000 shares

Expires 2027-03-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 100,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on March 27, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
March 12, 2019 Filed Mar 14, 2019 16:17 UTC
Danos OlivierChief Scientific Officer
Exercise / conversionCommon Stock 5,000 $20.35 $101,750.00
Disclosure

SEC source: 0001562180-19-001906 · primarydocument.xml · nonDerivative · entry 1

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2019 Filed Mar 7, 2019 16:23 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 3,068 $60.01 $184,110.68
Disclosure

SEC source: 0001562180-19-001801 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,215

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 25, 2019 Filed Feb 27, 2019 22:35 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionStock Option (Right to Buy) · Derivative 5,300 $0.00 Strike: $35.80 $0.00
Disclosure

SEC source: 0001562180-19-001472 · primarydocument.xml · derivative · entry 3

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,250

Underlying: Common Stock · 5,300 shares

Expires 2028-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
February 25, 2019 Filed Feb 27, 2019 22:35 UTC
Simpson CurranSVP, Product Development & CTO
SaleCommon Stock 5,300 $54.05 $286,465.00
Disclosure

SEC source: 0001562180-19-001472 · primarydocument.xml · nonDerivative · entry 2

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,500

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 25, 2019 Filed Feb 27, 2019 22:35 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionCommon Stock 5,300 $35.80 $189,740.00
Disclosure

SEC source: 0001562180-19-001472 · primarydocument.xml · nonDerivative · entry 1

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:19 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 8,066 $47.84 $385,877.44
Disclosure

SEC source: 0001562180-19-001047 · primarydocument.xml · nonDerivative · entry 4

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $47.57 to $48.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:19 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 3,522 $47.30 $166,590.60
Disclosure

SEC source: 0001562180-19-001047 · primarydocument.xml · nonDerivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,066

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $46.56 to $47.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 21:19 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 3,412 $45.96 $156,815.52
Disclosure

SEC source: 0001562180-19-001047 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 257,588

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $45.48 to $46.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 21:19 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-19-001047 · primarydocument.xml · derivative · entry 5

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,670

Underlying: Common Stock · 15,000 shares

Expires 2024-09-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 21:19 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 15,000 $0.85 $12,750.00
Disclosure

SEC source: 0001562180-19-001047 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 07, 2019 Filed Feb 11, 2019 16:20 UTC
Vasista VittalChief Financial Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 120,000 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-19-000874 · primarydocument.xml · derivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,900

Underlying: Common Stock · 120,000 shares

Expires 2024-09-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 424,900 shares, became exercisable as follows: 284,683 of the shares subject to the option are initial shares ("Initial Shares") and 140,217 of the shares subject to the option are contingent shares ("Contingent Shares"). 72,235 of the Initial Shares vested on September 17, 2014, 53,112 of the Initial Shares vested on September 17, 2015 and an additional 4,426 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.

F2 · derivative.exercise_date: (Continued from footnote 1) Notwithstanding the foregoing, 59,533 shares subject to this option that would otherwise have vested monthly between January 2018 and September 2018 were deemed vested as of December 31, 2015 on January 28, 2016 due to subsequent events.

Read SEC document
February 07, 2019 Filed Feb 11, 2019 16:20 UTC
Vasista VittalChief Financial Officer
Exercise / conversionCommon Stock 120,000 $0.85 $102,000.00
Disclosure

SEC source: 0001562180-19-000874 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,283

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:18 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionStock Option (Right to Buy) · Derivative 625 $0.00 Strike: $13.09 $0.00
Disclosure

SEC source: 0001562180-19-000815 · primarydocument.xml · derivative · entry 9

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,708

Underlying: Common Stock · 625 shares

Expires 2026-01-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 10,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:18 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,875 $0.00 Strike: $19.50 $0.00
Disclosure

SEC source: 0001562180-19-000815 · primarydocument.xml · derivative · entry 8

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 1,875 shares

Expires 2027-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:18 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionStock Option (Right to Buy) · Derivative 32,882 $0.00 Strike: $22.00 $0.00
Disclosure

SEC source: 0001562180-19-000815 · primarydocument.xml · derivative · entry 7

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,219

Underlying: Common Stock · 32,882 shares

Expires 2025-08-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:18 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionStock Option (Right to Buy) · Derivative 8,450 $0.00 Strike: $35.80 $0.00
Disclosure

SEC source: 0001562180-19-000815 · primarydocument.xml · derivative · entry 6

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,550

Underlying: Common Stock · 8,450 shares

Expires 2028-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:18 UTC
Simpson CurranSVP, Product Development & CTO
SaleCommon Stock 43,832 $50.08 $2,195,106.56
Disclosure

SEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 5

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,500

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:18 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionCommon Stock 625 $13.09 $8,181.25
Disclosure

SEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 4

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:18 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionCommon Stock 1,875 $19.50 $36,562.50
Disclosure

SEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 3

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,707

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:18 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionCommon Stock 32,882 $22.00 $723,404.00
Disclosure

SEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 2

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,832

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 05, 2019 Filed Feb 7, 2019 21:18 UTC
Simpson CurranSVP, Product Development & CTO
Exercise / conversionCommon Stock 8,450 $35.80 $302,510.00
Disclosure

SEC source: 0001562180-19-000815 · primarydocument.xml · nonDerivative · entry 1

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 01, 2019 Filed Feb 5, 2019 21:21 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-19-000759 · primarydocument.xml · derivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,670

Underlying: Common Stock · 45,000 shares

Expires 2024-09-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.

Read SEC document
February 01, 2019 Filed Feb 5, 2019 21:21 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 45,000 $0.85 $38,250.00
Disclosure

SEC source: 0001562180-19-000759 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 15, 2019 Filed Jan 17, 2019 21:18 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 3,140 $44.40 $139,416.00
Disclosure

SEC source: 0001562180-19-000337 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $44.13 to $44.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 15, 2019 Filed Jan 17, 2019 21:18 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 11,860 $43.70 $518,282.00
Disclosure

SEC source: 0001562180-19-000337 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,140

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $43.13 to $44.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 03, 2019 Filed Jan 7, 2019 16:24 UTC
Danos OlivierChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 48,000 $0.00 Strike: $40.82 $0.00
Disclosure

SEC source: 0001562180-19-000220 · primarydocument.xml · derivative · entry 1

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,000

Underlying: Common Stock · 48,000 shares

Expires 2029-01-03

F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2019 Filed Jan 7, 2019 21:20 UTC
Mills Kenneth T.Director · President and CEO
GrantStock Option (Right to Buy) · Derivative 190,000 $0.00 Strike: $40.82 $0.00
Disclosure

SEC source: 0001562180-19-000218 · primarydocument.xml · derivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock · 190,000 shares

Expires 2029-01-03

F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2019 Filed Jan 7, 2019 16:23 UTC
Vasista VittalChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 57,000 $0.00 Strike: $40.82 $0.00
Disclosure

SEC source: 0001562180-19-000219 · primarydocument.xml · derivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,000

Underlying: Common Stock · 57,000 shares

Expires 2029-01-03

F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2019 Filed Jan 7, 2019 21:25 UTC
Simpson CurranSVP, Product Development & CTO
GrantStock Option (Right to Buy) · Derivative 46,000 $0.00 Strike: $40.82 $0.00
Disclosure

SEC source: 0001562180-19-000221 · primarydocument.xml · derivative · entry 1

Simpson Curran · CIK 0001346164 · SVP, Product Development & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,000

Underlying: Common Stock · 46,000 shares

Expires 2029-01-03

F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2019 Filed Jan 7, 2019 21:27 UTC
Christmas Patrick J.SVP, General Counsel
GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $40.82 $0.00
Disclosure

SEC source: 0001562180-19-000222 · primarydocument.xml · derivative · entry 2

Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2029-01-03

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.